Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study.

ABSTRACT:

Background

The CADTH Common Drug Review was established in 2002 to prepare national health technology assessment reports to guide listing decisions for 18 participating drug plans. The aim of this study was to compare the nonmandatory recommendations from the Common Drug Review in Canada with the listing decisions of provincial payers to determine alignment.

Methods

We identified the recommendations issued by the Common Drug Review from Jan. 1, 2009, to Jan. 1, 2015, and compared these with the listing decisions of 3 provincial public payers (Alberta, British Columbia and Ontario) that participate in the Common Drug Review and the recommendations from Quebec.

Results

We identified 174 medicine-indication pairs in CADTH Common Drug Review reports issued from Jan. 1, 20

SUBMITTER: Allen N 

PROVIDER: S-EPMC5173476 | biostudies-literature | 2016 Oct-Dec

REPOSITORIES: biostudies-literature